National Historical Balance Sheet

NRC Stock

USD 19.48 0.06 0.31%

Trend analysis of National Research Corp balance sheet accounts such as Common Stock Shares Outstanding of 14.8 M provides information on National Research's total assets, liabilities, and equity, which is the actual value of National Research Corp to its prevalent stockholders. By breaking down trends over time using National Research balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining National Research Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether National Research Corp is a good buy for the upcoming year.

National Research Inventory

0.86

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Research Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

About National Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of National Research Corp at a specified time, usually calculated after every quarter, six months, or one year. National Research Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of National Research and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which National currently owns. An asset can also be divided into two categories, current and non-current.

National Research Balance Sheet Chart

At present, National Research's Other Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Total Liabilities is expected to grow to about 77.2 M, whereas Total Assets are forecasted to decline to about 80.7 M.

Total Assets Total Stockholder Equity Other Assets Common Stock Shares Outstanding Net Receivables Treasury Stock

Add Fundamental

Total Assets

Total assets refers to the total amount of National Research assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in National Research Corp books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Most accounts from National Research's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into National Research Corp current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Research Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

	2021	2022	2023	2024 (projected)
Total Stockholder Equity	85.3M	72.0M	49.0M	45.4M
Total Assets	157.5M	130.5M	122.4M	80.7M

Total Stockholder Equity Total Assets

National Research balance sheet Correlations

	Total Assets	Total Stockholder Equity	Other Assets	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Other Current Liab	Total Current Liabilities	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Non Current Liabilities Total	Other Current Assets	Property Plant And Equipment Gross	Total Current Assets	Short Long Term Debt Total	Intangible Assets	Short Term Debt	Other Liab	Long Term Debt
Total Assets		0.78	0.3	0.71	0.35	0.54	0.42	0.77	0.26	-0.34	0.02	0.23	0.71	0.89	0.65	0.71	0.87	0.3	0.79	0.18	0.81	0.21	-0.46	-0.08	0.47	0.12
Total Stockholder Equity	0.78		-0.11	0.42	-0.2	-0.02	-0.09	0.31	0.06	-0.6	0.58	0.22	0.78	0.55	0.21	0.78	0.57	-0.25	0.49	0.02	0.82	-0.31	-0.08	-0.21	0.07	-0.42
Other Assets	0.3	-0.11		0.39	0.92	0.72	0.68	0.31	0.43	0.43	-0.8	-0.33	0.13	0.28	0.59	0.13	0.41	0.81	0.7	0.6	0.28	0.82	-0.82	0.29	0.86	0.82
Common Stock Shares Outstanding	0.71	0.42	0.39		0.5	0.52	0.65	0.63	0.16	-0.29	-0.24	0.21	0.6	0.58	0.42	0.6	0.55	0.38	0.6	0.1	0.65	0.36	-0.69	-0.34	0.6	0.3
Other Stockholder Equity	0.35	-0.2	0.92	0.5		0.84	0.79	0.49	0.35	0.42	-0.91	-0.24	0.07	0.39	0.75	0.07	0.48	0.9	0.61	0.4	0.21	0.88	-0.81	0.24	0.83	0.89
Total Liab	0.54	-0.02	0.72	0.52	0.84		0.7	0.73	0.63	0.4	-0.7	0.04	0.06	0.67	0.7	0.06	0.61	0.92	0.67	0.56	0.25	0.88	-0.75	0.27	0.77	0.84
Other Current Liab	0.42	-0.09	0.68	0.65	0.79	0.7		0.63	0.21	0.08	-0.7	-0.18	0.17	0.44	0.53	0.17	0.52	0.64	0.43	0.25	0.26	0.64	-0.72	0.0	0.66	0.65
Total Current Liabilities	0.77	0.31	0.31	0.63	0.49	0.73	0.63		0.26	-0.13	-0.28	0.44	0.4	0.78	0.58	0.4	0.72	0.44	0.6	0.16	0.5	0.42	-0.52	0.13	0.55	0.3
Property Plant And Equipment Net	0.26	0.06	0.43	0.16	0.35	0.63	0.21	0.26		0.63	-0.26	-0.16	-0.26	0.49	0.12	-0.26	0.35	0.61	0.48	0.87	-0.05	0.67	-0.54	0.4	0.45	0.56
Net Debt	-0.34	-0.6	0.43	-0.29	0.42	0.4	0.08	-0.13	0.63		-0.59	-0.45	-0.77	0.0	0.09	-0.77	-0.04	0.59	0.08	0.57	-0.62	0.68	-0.31	0.62	0.26	0.65
Retained Earnings	0.02	0.58	-0.8	-0.24	-0.91	-0.7	-0.7	-0.28	-0.26	-0.59		0.3	0.26	-0.11	-0.55	0.26	-0.17	-0.85	-0.3	-0.31	0.17	-0.85	0.63	-0.29	-0.65	-0.91
Accounts Payable	0.23	0.22	-0.33	0.21	-0.24	0.04	-0.18	0.44	-0.16	-0.45	0.3		0.4	0.09	-0.13	0.4	-0.07	-0.23	0.06	-0.22	0.33	-0.25	0.07	-0.26	0.05	-0.29
Cash	0.71	0.78	0.13	0.6	0.07	0.06	0.17	0.4	-0.26	-0.77	0.26	0.4		0.32	0.31	1.0	0.39	-0.14	0.52	-0.12	0.97	-0.21	-0.22	-0.38	0.3	-0.25
Non Current Assets Total	0.89	0.55	0.28	0.58	0.39	0.67	0.44	0.78	0.49	0.0	-0.11	0.09	0.32		0.66	0.32	0.9	0.47	0.71	0.29	0.46	0.39	-0.43	0.11	0.4	0.29
Non Currrent Assets Other	0.65	0.21	0.59	0.42	0.75	0.7	0.53	0.58	0.12	0.09	-0.55	-0.13	0.31	0.66		0.31	0.75	0.67	0.62	0.08	0.42	0.52	-0.45	0.12	0.53	0.55
Cash And Short Term Investments	0.71	0.78	0.13	0.6	0.07	0.06	0.17	0.4	-0.26	-0.77	0.26	0.4	1.0	0.32	0.31		0.39	-0.14	0.52	-0.12	0.97	-0.21	-0.22	-0.38	0.3	-0.25
Net Receivables	0.87	0.57	0.41	0.55	0.48	0.61	0.52	0.72	0.35	-0.04	-0.17	-0.07	0.39	0.9	0.75	0.39		0.42	0.71	0.2	0.55	0.35	-0.53	0.14	0.5	0.26
Non Current Liabilities Total	0.3	-0.25	0.81	0.38	0.9	0.92	0.64	0.44	0.61	0.59	-0.85	-0.23	-0.14	0.47	0.67	-0.14	0.42		0.57	0.58	0.04	0.94	-0.69	0.25	0.71	0.98
Other Current Assets	0.79	0.49	0.7	0.6	0.61	0.67	0.43	0.6	0.48	0.08	-0.3	0.06	0.52	0.71	0.62	0.52	0.71	0.57		0.56	0.67	0.55	-0.69	0.21	0.74	0.45
Property Plant And Equipment Gross	0.18	0.02	0.6	0.1	0.4	0.56	0.25	0.16	0.87	0.57	-0.31	-0.22	-0.12	0.29	0.08	-0.12	0.2	0.58	0.56		0.06	0.67	-0.54	0.43	0.51	0.58
Total Current Assets	0.81	0.82	0.28	0.65	0.21	0.25	0.26	0.5	-0.05	-0.62	0.17	0.33	0.97	0.46	0.42	0.97	0.55	0.04	0.67	0.06		-0.03	-0.38	-0.26	0.45	-0.1
Short Long Term Debt Total	0.21	-0.31	0.82	0.36	0.88	0.88	0.64	0.42	0.67	0.68	-0.85	-0.25	-0.21	0.39	0.52	-0.21	0.35	0.94	0.55	0.67	-0.03		-0.77	0.46	0.73	0.93
Intangible Assets	-0.46	-0.08	-0.82	-0.69	-0.81	-0.75	-0.72	-0.52	-0.54	-0.31	0.63	0.07	-0.22	-0.43	-0.45	-0.22	-0.53	-0.69	-0.69	-0.54	-0.38	-0.77		-0.16	-0.94	-0.67
Short Term Debt	-0.08	-0.21	0.29	-0.34	0.24	0.27	0.0	0.13	0.4	0.62	-0.29	-0.26	-0.38	0.11	0.12	-0.38	0.14	0.25	0.21	0.43	-0.26	0.46	-0.16		0.13	0.23
Other Liab	0.47	0.07	0.86	0.6	0.83	0.77	0.66	0.55	0.45	0.26	-0.65	0.05	0.3	0.4	0.53	0.3	0.5	0.71	0.74	0.51	0.45	0.73	-0.94	0.13		0.69
Long Term Debt	0.12	-0.42	0.82	0.3	0.89	0.84	0.65	0.3	0.56	0.65	-0.91	-0.29	-0.25	0.29	0.55	-0.25	0.26	0.98	0.45	0.58	-0.1	0.93	-0.67	0.23	0.69

Click cells to compare fundamentals

National Research Account Relationship Matchups

National Research balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	110.7M	133.4M	157.5M	130.5M	122.4M	80.7M
Total Stockholder Equity	32.9M	64.3M	85.3M	72.0M	49.0M	45.4M
Other Assets	5.4M	8.9M	9.8M	5.7M	6.6M	6.9M
Common Stock Shares Outstanding	25.7M	25.7M	25.6M	25.1M	24.7M	14.8M
Liabilities And Stockholders Equity	110.7M	133.4M	157.5M	130.5M	122.4M	80.7M
Other Stockholder Equity	128.4M	128.1M	123.8M	97.2M	79.5M	83.4M
Total Liab	77.8M	69.1M	72.2M	58.4M	73.5M	77.2M
Other Current Liab	12.2M	10.9M	17.0M	12.6M	12.6M	7.2M
Total Current Liabilities	38.2M	31.7M	40.4M	33.4M	36.2M	23.7M
Property Plant And Equipment Net	13.5M	11.7M	12.4M	17.2M	30.3M	31.8M
Net Debt	20.7M	(4.1M)	(27.8M)	(2.8M)	32.3M	33.9M
Retained Earnings	(93.4M)	(61.4M)	(36.1M)	(25.2M)	(30.5M)	(29.0M)
Accounts Payable	4.9M	1.1M	1.9M	1.2M	1.3M	1.2M
Cash	13.5M	34.7M	54.4M	25.0M	6.7M	6.3M
Non Current Assets Total	81.5M	79.3M	83.8M	86.7M	98.1M	58.5M
Non Currrent Assets Other	10.1M	10.3M	9.8M	7.9M	4.7M	4.5M
Cash And Short Term Investments	13.5M	34.7M	54.4M	25.0M	6.7M	6.3M
Net Receivables	11.7M	14.2M	13.8M	14.6M	12.5M	9.1M
Non Current Liabilities Total	39.6M	37.4M	31.8M	25.0M	37.3M	39.1M
Other Current Assets	3.9M	5.2M	5.5M	4.1M	5.2M	3.8M
Property Plant And Equipment Gross	15.2M	13.0M	46.6M	17.2M	65.9M	69.2M
Total Current Assets	29.2M	54.1M	73.7M	43.7M	24.4M	30.4M
Accumulated Other Comprehensive Income	(1.6M)	(2.9M)	(2.2M)	(2.4M)	(2.4M)	0.0
Short Long Term Debt Total	34.7M	30.6M	26.5M	22.2M	39.0M	40.9M
Intangible Assets	1.7M	1.4M	1.8M	1.6M	1.5M	1.4M
Short Term Debt	4.4M	5.0M	5.2M	5.3M	7.2M	7.6M
Other Liab	8.1M	10.9M	9.5M	6.9M	8.0M	8.4M
Long Term Debt	29.8M	26.5M	22.3M	17.7M	29.5M	30.9M
Treasury Stock	(33.7M)	(43.7M)	(50.1M)	(78.3M)	(70.4M)	(66.9M)
Property Plant Equipment	13.5M	11.7M	12.4M	17.2M	19.8M	14.1M
Current Deferred Revenue	16.6M	15.6M	17.2M	15.2M	14.8M	14.4M
Good Will	57.8M	57.9M	57.3M	61.6M	55.5M	52.7M
Retained Earnings Total Equity	(93.4M)	(61.4M)	(36.1M)	(25.2M)	(22.7M)	(21.5M)
Deferred Long Term Liab	4.2M	4.6M	3.8M	5.3M	4.7M	3.4M
Net Tangible Assets	32.9M	64.3M	23.7M	8.8M	10.1M	9.6M
Capital Surpluse	162.2M	171.8M	173.9M	175.5M	201.8M	110.9M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

When determining whether National Research Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National Research's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Research Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Research Corp Stock:

How To Invest In National

Details

Is National Stock a good investment?

Details

What is National Research's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Research. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Research listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.25)

Dividend Share

0.48

Earnings Share

1.12

Revenue Per Share

6.013

Quarterly Revenue Growth

(0.06)

The market value of National Research Corp is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Research's value that differs from its market value or its book value, called intrinsic value, which is National Research's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Research's market value can be influenced by many factors that don't directly affect National Research's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between National Research's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Research is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Research's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

National Historical Balance Sheet

National Research Inventory

0.86

About National Balance Sheet Analysis

National Research Balance Sheet Chart

Total Assets

Total Stockholder Equity

Common Stock Shares Outstanding

National Research balance sheet Correlations

National Research Account Relationship Matchups

High Positive Relationship

High Negative Relationship

National Research balance sheet Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Long Term Debt	+ 0.98	Non Current Liabilities Total
Total Current Assets	+ 0.97	Cash
Total Current Assets	+ 0.97	Cash And Short Term Investments
Short Long Term Debt Total	+ 0.94	Non Current Liabilities Total
Long Term Debt	+ 0.93	Short Long Term Debt Total

Other Liab	- 0.94	Intangible Assets
Long Term Debt	- 0.91	Retained Earnings
Retained Earnings	- 0.91	Other Stockholder Equity
Short Long Term Debt Total	- 0.85	Retained Earnings
Non Current Liabilities Total	- 0.85	Retained Earnings
Intangible Assets	- 0.82	Other Assets